Notes of the cash flow statements
for the year ended 30 September 2016
| COMPANY | GROUP | |||||||||||||
| 2016 | 2015 Restated* |
(R’million) | Note | 2016 | 2015 Restated* |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | Cash operating profit/(loss) | |||||||||||||
| (1,8) | 4,6 | Operating profit/(loss) before abnormal items and impairments – continuing operations | 4 154,1 | 3 633,2 | ||||||||||
| Add back: | ||||||||||||||
| Depreciation | 558,8 | 662,1 | ||||||||||||
| Share-based payment expenses | 88,9 | 29,2 | ||||||||||||
| Provision for post-retirement medical aid | 22,9 | 16,7 | ||||||||||||
| Amortisation | 11,9 | 23,8 | ||||||||||||
| Loss on disposal of plant, equipment and vehicles | 0,2 | 4,4 | ||||||||||||
| 1,2 | (9,7) | Other non-cash items | – | 27,0 | ||||||||||
| (0,6) | (5,1) | Cash operating profit/(loss) | 4 836,8 | 4 396,4 | ||||||||||
| B | Working capital changes | |||||||||||||
| Increase in inventories | (518,7) | (917,9) | ||||||||||||
| 9,1 | 8,4 | (Increase)/decrease in trade and other receivables | (282,0) | (77,4) | ||||||||||
| (0,7) | 0,3 | Increase/(decrease) in trade and other payables | 196,7 | 183,7 | ||||||||||
| 8,4 | 8,7 | Working capital changes | (604,0) | (811,6) | ||||||||||
| C | Taxation paid | |||||||||||||
| – | (1,8) | Amounts payable at the beginning of the year, net | (38,9) | (193,5) | ||||||||||
| (48,1) | (42,5) | Income statement charge – continuing operations | (1 220,6) | (977,3) | ||||||||||
| Income statement charge – discontinued operation | – | (230,9) | ||||||||||||
| 0,9 | (8,1) | Deferred tax | 67,1 | 201,0 | ||||||||||
| Exchange rate difference and other non-cash items | 11,5 | 3,0 | ||||||||||||
| (10,7) | – | Amounts payable/(receivable) at the end of the year, net | 73,5 | 38,9 | ||||||||||
| (57,9) | (52,4) | Total taxation paid | (1 107,4) | (1 158,8) | ||||||||||
| D | Dividends paid | |||||||||||||
| (1 831,0) | (1 785,6) | Per statement of changes in equity | (1 629,9) | (1 574,6) | ||||||||||
| Dividends paid to outside shareholders | (31,2) | (68,4) | ||||||||||||
| (1 831,0) | (1 785,6) | Total dividends paid | (1 661,1) | (1 643,0) | ||||||||||
| E | Purchase of property, plant, equipment | |||||||||||||
| Replacement | (638,9) | (677,8) | ||||||||||||
| Expansion | (306,5) | (203,8) | ||||||||||||
| (945,4) | (881,6) | |||||||||||||
| F | Increase in shareholder funding | |||||||||||||
| – | 9,1 | Proceeds from issue of share capital | – | 9,1 | ||||||||||
| – | 9,1 | – | 9,1 | |||||||||||
| G | Cash and cash equivalents at the beginning of the year | |||||||||||||
| 127,1 | 270,0 | Cash resources | 1 051,6 | 1 160,3 | ||||||||||
| – | – | Short-term borrowings regarded as cash and cash equivalents | 27.5 | (3 178,4) | (3 086,2) | |||||||||
| 127,1 | 270,0 | (2 126,8) | (1 925,9) | |||||||||||
| H | Cash and cash equivalents at the end of the year | |||||||||||||
| 282,1 | 127,1 | Cash resources | 737,0 | 1 051,6 | ||||||||||
| – | – | Short-term borrowings regarded as cash and cash equivalents | 27.5 | (1 612,0) | (3 178,4) | |||||||||
| 282,1 | 127,1 | (875,0) | (2 126,8 | |||||||||||
| * | The comparatives have been restated for the retrospective reclassification relating to the treatment of foreign exchange profits and losses on foreign cash balances and loans of a funding nature previously included in operating income/(loss) and now reclassified to net finance costs. Refer to note 7 for further details. |